Burns Matteson Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Buy
1,785
+117
+7% +$43.4K 0.22% 73
2026
Q1
$488K Sell
1,668
-4
-0.2% -$1.31K 0.18% 120
2025
Q4
$586K Buy
+1,672
New +$565K 0.21% 80
2024
Q3
Sell
-645
Closed -$350K 177
2024
Q2
$350K Buy
+645
New +$341K 0.22% 89
2023
Q4
Sell
-1,296
Closed -$564K 147
2023
Q3
$564K Buy
+1,296
New +$588K 0.36% 77
2023
Q2
Sell
-1,168
Closed -$537K 160
2023
Q1
$537K Sell
1,168
-5
-0.4% -$2.38K 0.34% 84
2022
Q4
$602K Buy
+1,173
New +$596K 0.4% 76
2022
Q3
Sell
-1,529
Closed -$738K 134
2022
Q2
$738K Buy
+1,529
New +$756K 0.52% 45
2022
Q1
Sell
-1,605
Closed -$744K 136
2021
Q4
$744K Buy
+1,605
New +$675K 0.51% 54
2021
Q3
Sell
-937
Closed -$358K 144
2021
Q2
$358K Buy
+937
New +$358K 0.28% 81

Other funds holding ELV

Burns Matteson Capital Management's ELV Position: Q2 2026 in Review

Burns Matteson Capital Management increased its Elevance Health (ELV) stake by 7% in Q2 2026, buying an estimated $43.4K and bringing the position to 1,785 shares worth $690K. The position accounts for 0.22% of the portfolio, ranked #73.

Burns Matteson Capital Management first reported a position in ELV in Q2 2021 and has held it in 10 quarters since. The position peaked at $744K in Q4 2021. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Burns Matteson Capital Management held 1,785 shares of Elevance Health worth $690K as of Q2 2026.
  • Burns Matteson Capital Management bought 117 Elevance Health shares in Q2 2026, an estimated $43.4K.
  • Elevance Health made up 0.22% of Burns Matteson Capital Management's portfolio in Q2 2026, its #73 holding.
  • Burns Matteson Capital Management first reported a position in Elevance Health in Q2 2021 and has held it in 10 quarters since.
  • Burns Matteson Capital Management's Elevance Health position peaked at $744K in Q4 2021.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Burns Matteson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.